A fractional-order model for optimizing combination therapy in heterogeneous lung cancer: integrating immunotherapy and targeted therapy to minimize side effectsDavid Amilo, Yekini Shehu, Evren Hınçal et al.|Scientific Reports|2024Cited by 24